Drug Screening Market: Staregic Developments in Emerging Markets

The drug screening market is expected to reach USD 8.63 Billion by 2022 from USD 5.32 Billion in 2017, at a CAGR of 10.2%.

Factors such as growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and the availability of government funding in major markets are driving the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

Drug screening market segmentation:

•             based on products

•             based on diseases

•             based on techniques,

•             based on end users

•             based on regions.

The Major Players Opearting in the Drug screening Market:

Most key players adopted product launches as the primary growth strategy between 2014 and 2017. Some of the companies that adopted this strategy include Alfa Scientific Designs, Thermo Fisher, and Premier Biotech.

Geographical Detailed Analysis for Drug screening Market:

North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as growing consumption of illicit drugs, the availability of government funding to curb drug addiction, presence of laws supporting drug screening, and growing burden of road accidents due to alcohol consumption in the region.

The drug screening market is highly competitive with the presence of several small and big players. Some of the players offering products for drug screening market include Alere (US), Thermo Fisher (US), Siemens Healthineers (Germany), Alfa Scientific Designs (US), Roche (Switzerland), MPD, Inc. (US), Shimadzu (Japan), OraSure (US), Lifeloc (US), and Drägerwerk (Germany). On the other hand, LabCorp (US), Quest Diagnostics (US), Psychemedics (US), Omega Laboratories (US), CRL (US), SureHire (Canada), and CannAmm (Canada).

Read More in Detailed (Drug screening Market ): 

https://www.marketsandmarkets.com/PressReleases/drug-alcohol-screening.asp

Infectious Disease Diagnostics Market Size, Analysis, Trends and Market Forecast

The global infectious disease diagnostics market is expected to reach USD 25.43 billion by 2027 from USD 15.57 billion in 2018, at a CAGR of 5.6%.

The increasing global prevalence of infectious diseases, the shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics are some the factors driving the growth of this market.

Growth in this market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589

The global infectious disease diagnostics market segmentation:

·         Based on the disease type,

·         Based on end user

·         Based on technology

The Major Players Opearting in Infectious Disease Diagnostics Market :

The key players in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), biomérieux (France), Bio-Rad (US), and Roche (Switzerland). These players focus on inorganic strategies such as acquisitions, partnerships, agreements, collaborations and as well as organic strategies such as expansions and product launches & approvals to sustain their growth in the market.

Geographical Detailed Analysis for Infectious Disease Diagnostics Market:

North America accounted for the largest share of the global infectious disease diagnostics market. This largest share is attributed to the presence of a highly developed healthcare system, increasing prevalence of infectious diseases, the presence of a large number of leading national clinical laboratories, and easy accessibility to technologically advanced instruments in the region.

Read More in Detailed (Infectious Disease Diagnostics Market): https://www.marketsandmarkets.com/PressReleases/infectious-disease-diagnostics.asp

Pharmaceutical Robots Market - Scope, Size, Share, Analysis, Industry Trends & Forecast

The overall pharmaceutical robotic systems market is expected to grow from USD 64.37 million in 2016 to USD 119.46 million by 2021, at a CAGR of 13.2% from 2016 to 2021.

Benefits offered by robotic systems in pharmaceutical manufacturing is a key factor driving the growth of pharmaceutical robots market. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210985096

Pharmaceutical robotic systems market segmentation:

·         Based on type

·         based on application

·         Based on region

The Major Players Operating in the Pharmaceutical robotic systems market:

Key players in the Pharmaceutical Robots Market include Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan). These players are increasingly undertaking marketing and promotions, expansions, agreements, alliances, collaborations, partnerships, product launches, acquisitions, product enhancements, market developments, funding, restructuration, and rebranding to develop and introduce new technologies and products in the market.

Geographical Detailed Analysis for Pharmaceutical robotic systems market:

The pharmaceutical robots market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, Asia-Pacific accounted for the largest share of the global market. This segment is also projected to register the highest CAGR of 14.1% during the forecast period. Factors such as the increase in domestic industrial robot companies, flourishing pharmaceutical industry, increasing number of conferences and exhibitions, investment and funding in the robots industry, and Japan’s Robot Strategy are driving the growth of the APAC pharmaceutical robots market.

 

Read More in Detailed (Pharmaceutical robotic systems market): https://www.marketsandmarkets.com/PressReleases/pharmaceutical-robot.asp

Gas Chromatography Market size, Forecast, Trend Analysis & Industry Players

The overall gas chromatography market is expected to reach USD 3671.0 million by 2022 from USD 2647.0 million in 2016, at a CAGR of 6.2%.

The increasing crude & shale oil production, increasing importance of waste water treatment, rise in adoption of GC-MS, initiatives to reduce environmental pollution levels, growing food safety concerns and increased importance of chromatography tests in drug are the key factors driving the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10165677

Gas chromatography market segmentation:

·         basis of instruments

·         basis of accessories and consumables

·         basis of end users

·         basis of regions

The Major Players Operating in the Gas chromatography market

The gas chromatography market is dominated by Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), and PerkinElmer, Inc. (U.S.).

The prominent players in the gas chromatography market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), PerkinElmer, Inc. (U.S.), Danaher Corporation (U.S.), Scion Instruments (Techcomp USA Inc.), LECO Corporation (U.S.), Merck KGaA (Germany), Falcon Analytical Systems & Technology, LLC (U.S.), Restek Corporation (U.S.), Dani Instruments S.p.A. (Italy), and Chromatotec (France).

Geographical Detailed Analysis for Gas chromatography market:

The geographic segments in this report include North America, Europe, Asia-Pacific, and the RoW. Of these, North America accounted for the largest sh gas chromatography market are of the market in 2016. Factors such as increase in the U.S. shale gas production, growing funding for environmental testing and clean-up in Canada, increasing funding for R&D activities in healthcare & environmental industries, and growth in food testing industries are driving the growth of the North American gas chromatography market.

Read More in Detailed (Gas chromatography market): https://www.marketsandmarkets.com/PressReleases/gas-chromatography.asp

Analytical Laboratory Services Market- Analysis, Industry Size, Opportunities and Forecast

According to the new market research report "Analytical Laboratory Services Market by Public Health Organization, - by types of services (Stability, Raw Material, Physical Characterization, Method Validation, Microbial Testing, Environmental Monitoring, Bioanalytical Testing) - Forecast to 2021", published by MarketsandMarkets™, The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period.

Don’t miss out on business opportunities in Analytical Laboratory Services Market, visit: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65590498

The overall market, by public health organization is positively impacted by factors such as the growing expenditure on drugs and medical devices by public health organizations, government initiatives to strengthen analytical testing capabilities, increasing number of drug approvals & clinical trials, and rising demand for specialized analytical testing services.

However, complex and innovative pharmaceutical products requiring a distinctive analytical testing approach is the major challenge hampering the growth of government support on analytical laboratory services.

Browse and in-depth TOC on "Analytical Laboratory Services Market"

37  - Tables

7 - Figures

68 - Pages

On the basis of type of service, the spend assessment is segmented into eight segments, namely, bioanalytical testing, batch release testing, stability testing, raw material testing, physical characterization, method validation, microbial testing, and environmental monitoring.

Read More Report @ https://www.marketsandmarkets.com/PressReleases/analytical-laboratory-services.asp

Geographically, the market, by public health organization is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America commanded the largest share, followed by Europe, Asia-Pacific, and the RoW. The major share of this region can be attributed to the high expenditure on quality testing, strong regulatory scenario, increasing number of clinical trials, and the well-established federal testing laboratories in the region. Moreover, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. This can be attributed to the fast-growing pharmaceutical industry in this region, increased government expenditure on healthcare, increasing number of highly competitive and extremely fragmented pharmaceutical companies, and increased spending by governments to set up new laboratories in Asian countries.

To read research insights, visit: https://www.marketsandmarkets.com/Market-Reports/analytical-laboratory-services-market-65590498

The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period. The key trends for increase in market, by public health organization are the growing expenditure on drugs and medical devices by public health organizations, steps by the government to build up strong analytical testing abilities, increasing number of drug approvals and clinical trials, and rising demand for specialized analytical testing services. However, complex and innovative pharmaceutical products requiring a distinctive analytical testing approach is the major challenge hampering the growth of government support

To know about the assumptions considered for the study, download the pdf brochure, visit:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65590498

Anatomic Pathology Market - Scope, Size, Share, Analysis, Statistics & Trends

The global anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1% from 2016 to 2021.

The increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure are the major factors driving the growth of this market.

Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.

To know about the assumptions considered for the study, download the pdf brochure , here: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

Anatomic Pathology Market segmentation:

·         by Product & Service

·         by Application

·         by Region

The Major Players Operating in the Anatomic Pathology Market:

Key players operating in the market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).

Geographical Detailed Analysis for Anatomic Pathology Market:

The anatomic pathology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The growing prevalence of chronic diseases, rapidly increasing aging population, rising acceptance of personalized medicine, growing academic and government investments in diagnostic research, and the presence of a large number of major market players in this region are further driving the growth of this Anatomical pathology market.

Read More in Detailed (Anatomic Pathology Market):

 https://www.marketsandmarkets.com/PressReleases/anatomic-pathology.asp

Anatomic Pathology Market - Scope, Size, Share, Analysis, Statistics & Trends

The global anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1% from 2016 to 2021.

The increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure are the major factors driving the growth of this market.

Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.

To know about the assumptions considered for the study, download the pdf brochure , here: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

Anatomic Pathology Market segmentation:

·         by Product & Service

·         by Application

·         by Region

The Major Players Operating in the Anatomic Pathology Market:

Key players operating in the market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).

Geographical Detailed Analysis for Anatomic Pathology Market:

The anatomic pathology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The growing prevalence of chronic diseases, rapidly increasing aging population, rising acceptance of personalized medicine, growing academic and government investments in diagnostic research, and the presence of a large number of major market players in this region are further driving the growth of this Anatomical pathology market.

Read More in Detailed (Anatomic Pathology Market):

 https://www.marketsandmarkets.com/PressReleases/anatomic-pathology.asp

Needle Free Injection System Market Size, Analysis, Growth, Forecast and Industry Trends

According to the new market research report "Needle-Free Injection System Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021", published by MarketsandMarkets™, The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.

Don’t miss out on business opportunities in Needle-Free Injection System Market @ https://www.marketsandmarkets.com/Market- Reports/needle-free-injection-system-market-165815861.html

Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection system over the conventional needle injection may hinder the growth of this market during the forecast period.

Browse and in-depth TOC on "Needle-Free Injection System Market"

151 - Tables

33 - Figures

183 - Pages

The report segments the market based on product, technology, type, site of delivery, applications, end user and regions. Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.

Make an Inquiry Prior To Purchase this research study @https://www.marketsandmarkets.com/PressReleases/needle-free-injection-system.asp

The report "Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021", The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.Browse 151 market data tables and 33 figures spread through 183 pages and in-depth TOC on “Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021”

Order a copy of “Needle-Free Injection System Market” research study @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

Needle Free Injection System Market Size, Analysis, Growth, Forecast and Industry Trends

According to the new market research report "Needle-Free Injection System Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021", published by MarketsandMarkets™, The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.

Don’t miss out on business opportunities in Needle-Free Injection System Market @ https://www.marketsandmarkets.com/Market- Reports/needle-free-injection-system-market-165815861.html

Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection system over the conventional needle injection may hinder the growth of this market during the forecast period.

Browse and in-depth TOC on "Needle-Free Injection System Market"

151 - Tables

33 - Figures

183 - Pages

The report segments the market based on product, technology, type, site of delivery, applications, end user and regions. Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.

Make an Inquiry Prior To Purchase this research study @https://www.marketsandmarkets.com/PressReleases/needle-free-injection-system.asp

The report "Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021", The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.Browse 151 market data tables and 33 figures spread through 183 pages and in-depth TOC on “Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021”

Order a copy of “Needle-Free Injection System Market” research study @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

Wireless Health Market Research Report, Market size, Growth, Analysis and forecast

The global wireless health market is projected to reach USD 110.12 Billion by 2020 from USD 39.03 Billion in 2015, at a CAGR of 23.1% during the forecast period of 2015 to 2020.

The market is expected to witness the highest growth in the Asia-Pacific region in the coming years. Growth in the Asia-Pacific region can be attributed to factors such as increasing population, growing internet penetration, rising medical tourism, increasing government initiatives for eHealth, and growing demand for quality healthcare.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=551

Wireless health market segmentation:

·         Basis of components

·         Basis of technology

·         Basis of applications

·         Basis of end users

·         Basis of region

The Major Players Operating in the Wireless health market:

Allscripts Healthcare Solutions, Inc. (U.S.), AT &T, Inc. (U.S.), Cerner Corporation (U.S.), Omron Corporation (U.S.), Philips Healthcare (U.S.), Verizon Communications, Inc. (U.S.), Qualcomm, Inc. (U.S.), Aerohive Networks, Inc.(U.S.), Vocera Communications, Inc. (U.S.), and Alcatel-Lucent (U.S.) are some of the key players in the wireless health market worldwide.

The Major Players Operating in the Wireless health market:

Federal mandates such as Meaningful Use Stage II and growing adoption of wireless health devices among the elderly and patients suffering from chronic illnesses are some of the factors driving the growth of the wireless health market.

The global wireless market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America accounts for the largest share of the market, followed by Europe and Asia-Pacific. The large share of the North American wireless health market can primarily be attributed to the federal mandates in the U.S. and rising digital health measures in Canada. The Asia-Pacific region is estimated to grow rapidly during the forecast period due to rising internet penetration, growing medical tourism, and increasing government initiatives for eHealth.

Read More in Detailed (Wireless health market):

https://www.marketsandmarkets.com/PressReleases/wireless-health.asp

Health Information Exchange Market – Industry Analysis, Size, Share, Strategies and Forecast

The health information exchange market is projected to reach USD 1,545.0 million by 2020 from USD 990.6 million in 2015, at a CAGR of 9.3% during the forecast period.

Federal mandates like Meaningful use, growing patient-centric approach in healthcare delivery, increasing EHR adoption rate, and need to curtail healthcare cost are some of the key factors driving the growth of market.

Health information exchange (HIE) involves the electronic movement of health-related information among organizations according to nationally recognized standards. HIE aims to facilitate the access and retrieval of clinical data to provide safer, timelier, efficient, effective, equitable, patient -centered care.

Download PDF Brochure: https://www.marketsandmarkets.com/PressReleases/healthcare-information-exchange.asp

Health information exchange Market segmentation:

•             based on products

•             based on diseases

•             based on techniques

•             based on end users

•             based on regions

The Major Players Opearting in the Health information exchange Test Market:

Key players in this market include Allscripts Healthcare Solutions, Inc. (U.S.), Relayhealth Corporation (U.S.), Infor, Inc. (U.S.), Cerner Corporation (U.S.), and eClinicalWorks (U.S.) among others. These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.

Geographical Detailed Analysis for Health information exchange Market:

In 2015, North America is poised to account for the largest share of the HIE market, followed by Europe and Asia-Pacific. However, the Asia-Pacific region is slated to grow at the highest CAGR during the forecast period. The large share of the North American health information exchange market can primarily be attributed to the federal mandates in the U.S., rising number of accountable care organizations’ ACO’s as end users for HIE platforms in the U.S., Canada’s efforts to enhance healthcare delivery, and digital health measures in Canada.

Allscripts Healthcare Solutions, Inc. (U.S.), RelayHealth Corporation (U.S.), Cerner Corporation (U.S.), eClinicalWorks (U.S.), NextGen Healthcare Information Systems, LLC (U.S.), Infor, Inc. (U.S.), Optum, Inc. (U.S.), Epic Corporation Inc. (U.S.), Orion Health (New Zealand) are some of the key players in the health information exchange market worldwide.

Read More in Detailed (Health information exchange Market): https://www.marketsandmarkets.com/PressReleases/healthcare-information-exchange.asp

Digital Therapeutics Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast

The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.

The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.

However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.

Download PDF Brochure: : https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.asp

Digital Therapeutics Market segmentation:

•             based on products

•             based on diseases

•             based on techniques,

•             based on end users

•             based on regions.

The Major Players Opearting in the Digital Therapeutics Market:

Key players in the digital therapeutics market include Proteus Digital Health, Inc. (U.S.), Omada Health Inc. (U.S.), WellDoc Inc. (U.S.), Livongo Health (U.S.), Noom Inc. (U.S.), Ginger.io Inc. (U.S.), Propeller Health (U.S.), 2Morrow Inc. (U.S.), Canary Health Inc. (U.S.), Mango Health, Inc. (U.S.), and Physitrack Limited (U.K.). Click Therapeutics, Inc. (U.S.), Pear Therapeutics, Inc., (U.S.), Akili Interactive Labs, Inc. (U.S.) and Wellthy Therapeutics Pvt. Ltd (India) are some of the emerging players in this market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Geographical Detailed Analysis for Digital Therapeutics Market:

The global digital therapeutics market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2016. This large share can be attributed to various factors, including growing incidence of chronic diseases, government initiatives to support technological advancements in the field of digital therapeutics, and a growing influx of new startup companies in the market.

Prominent players in the digital therapeutics market include Proteus Digital Health, Inc. (U.S.), Omada Health Inc. (U.S.), WellDoc Inc. (U.S.), Livongo Health (U.S.), Noom Inc. (U.S.), Ginger.io Inc. (U.S.), Propeller Health (U.S.), 2Morrow Inc. (U.S.), Canary Health Inc. (U.S.), and Mango Health, Inc. (U.S.).

Read More in Detailed (Digital Therapeutics Market): 

https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.asp

Digital Therapeutics Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast

The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.

The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.

However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.

Download PDF Brochure: : https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.asp

Digital Therapeutics Market segmentation:

•             based on products

•             based on diseases

•             based on techniques,

•             based on end users

•             based on regions.

The Major Players Opearting in the Digital Therapeutics Market:

Key players in the digital therapeutics market include Proteus Digital Health, Inc. (U.S.), Omada Health Inc. (U.S.), WellDoc Inc. (U.S.), Livongo Health (U.S.), Noom Inc. (U.S.), Ginger.io Inc. (U.S.), Propeller Health (U.S.), 2Morrow Inc. (U.S.), Canary Health Inc. (U.S.), Mango Health, Inc. (U.S.), and Physitrack Limited (U.K.). Click Therapeutics, Inc. (U.S.), Pear Therapeutics, Inc., (U.S.), Akili Interactive Labs, Inc. (U.S.) and Wellthy Therapeutics Pvt. Ltd (India) are some of the emerging players in this market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Geographical Detailed Analysis for Digital Therapeutics Market:

The global digital therapeutics market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2016. This large share can be attributed to various factors, including growing incidence of chronic diseases, government initiatives to support technological advancements in the field of digital therapeutics, and a growing influx of new startup companies in the market.

Prominent players in the digital therapeutics market include Proteus Digital Health, Inc. (U.S.), Omada Health Inc. (U.S.), WellDoc Inc. (U.S.), Livongo Health (U.S.), Noom Inc. (U.S.), Ginger.io Inc. (U.S.), Propeller Health (U.S.), 2Morrow Inc. (U.S.), Canary Health Inc. (U.S.), and Mango Health, Inc. (U.S.).

Read More in Detailed (Digital Therapeutics Market): https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.asp